antibodies Archives - Journal for Clinical Studies

Current Edition

Regional News

GlaxoSmithKline and Vir’s sotrovimab stands up to omicron despite other COVID antibodies falling short

Amid reports that COVID-19 antibody treatments from Regeneron and Eli Lilly lose their effectiveness against the omicron variant, GlaxoSmithKline and Vir Biotechnolog...

8 December 2021 Regional News antibodies | Celltrion

Continue Reading →

news

GamaMabs Pharma sees two peer-reviewed articles published in Oncotarget, detailing the anti-tumor activity of GM102/3C23K

GamaMabs Pharma, a biotechnology company developing optimized therapeutic antibodies targeting AMHR2 for the treatment of cancer, today announces that two peer-review...

6 December 2017 news antibodies | cancer

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Vaccine – Shorten Start-Up Timelines in Vaccine Trials

Current Edition

GlaxoSmithKline and Vir’s sotrovimab stands up to omicron despite other COVID antibodies falling short

GamaMabs Pharma sees two peer-reviewed articles published in Oncotarget, detailing the anti-tumor activity of GM102/3C23K

Journal for Clinical Studies